Cargando…
Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study
Background: Bladder cancer (BCa) emits specific volatile organic compounds (VOCs) in the urine headspace that can be detected by an electronic nose. The diagnostic performance of an electronic nose in detecting BCa was investigated in a pilot study. Methods: A prospective, single-center, controlled,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584426/ https://www.ncbi.nlm.nih.gov/pubmed/34768503 http://dx.doi.org/10.3390/jcm10214984 |
_version_ | 1784597446479839232 |
---|---|
author | Bassi, PierFrancesco Di Gianfrancesco, Luca Salmaso, Luigi Ragonese, Mauro Palermo, Giuseppe Sacco, Emilio Giancristofaro, Rosa Arboretti Ceccato, Riccardo Racioppi, Marco |
author_facet | Bassi, PierFrancesco Di Gianfrancesco, Luca Salmaso, Luigi Ragonese, Mauro Palermo, Giuseppe Sacco, Emilio Giancristofaro, Rosa Arboretti Ceccato, Riccardo Racioppi, Marco |
author_sort | Bassi, PierFrancesco |
collection | PubMed |
description | Background: Bladder cancer (BCa) emits specific volatile organic compounds (VOCs) in the urine headspace that can be detected by an electronic nose. The diagnostic performance of an electronic nose in detecting BCa was investigated in a pilot study. Methods: A prospective, single-center, controlled, non-randomized, phase 2 study was carried out on 198 consecutive subjects (102 with proven BCa, 96 controls). Urine samples were evaluated with an electronic nose provided with 32 volatile gas analyzer sensors. The tests were repeated at least two times per sample. Accuracy, sensitivity, specificity, and variability were evaluated using mainly the non-parametric combination method, permutation tests, and discriminant analysis classification. Results: Statistically significant differences between BCa patients and controls were reported by 28 (87.5%) of the 32 sensors. The overall discriminatory power, sensitivity, and specificity were 78.8%, 74.1%, and 76%, respectively; 13/96 (13.5%) controls and 29/102 (28.4%) BCa patients were misclassified as false positive and false negative, respectively. Where the most efficient sensors were selected, the sensitivity and specificity increased up to 91.1% (72.5–100) and 89.1% (81–95.8), respectively. None of the tumor characteristics represented independent predictors of device responsiveness. Conclusions: The electronic nose might represent a potentially reliable, quick, accurate, and cost-effective tool for non-invasive BCa diagnosis. |
format | Online Article Text |
id | pubmed-8584426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85844262021-11-12 Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study Bassi, PierFrancesco Di Gianfrancesco, Luca Salmaso, Luigi Ragonese, Mauro Palermo, Giuseppe Sacco, Emilio Giancristofaro, Rosa Arboretti Ceccato, Riccardo Racioppi, Marco J Clin Med Article Background: Bladder cancer (BCa) emits specific volatile organic compounds (VOCs) in the urine headspace that can be detected by an electronic nose. The diagnostic performance of an electronic nose in detecting BCa was investigated in a pilot study. Methods: A prospective, single-center, controlled, non-randomized, phase 2 study was carried out on 198 consecutive subjects (102 with proven BCa, 96 controls). Urine samples were evaluated with an electronic nose provided with 32 volatile gas analyzer sensors. The tests were repeated at least two times per sample. Accuracy, sensitivity, specificity, and variability were evaluated using mainly the non-parametric combination method, permutation tests, and discriminant analysis classification. Results: Statistically significant differences between BCa patients and controls were reported by 28 (87.5%) of the 32 sensors. The overall discriminatory power, sensitivity, and specificity were 78.8%, 74.1%, and 76%, respectively; 13/96 (13.5%) controls and 29/102 (28.4%) BCa patients were misclassified as false positive and false negative, respectively. Where the most efficient sensors were selected, the sensitivity and specificity increased up to 91.1% (72.5–100) and 89.1% (81–95.8), respectively. None of the tumor characteristics represented independent predictors of device responsiveness. Conclusions: The electronic nose might represent a potentially reliable, quick, accurate, and cost-effective tool for non-invasive BCa diagnosis. MDPI 2021-10-27 /pmc/articles/PMC8584426/ /pubmed/34768503 http://dx.doi.org/10.3390/jcm10214984 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bassi, PierFrancesco Di Gianfrancesco, Luca Salmaso, Luigi Ragonese, Mauro Palermo, Giuseppe Sacco, Emilio Giancristofaro, Rosa Arboretti Ceccato, Riccardo Racioppi, Marco Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title | Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title_full | Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title_fullStr | Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title_full_unstemmed | Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title_short | Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study |
title_sort | improved non-invasive diagnosis of bladder cancer with an electronic nose: a large pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584426/ https://www.ncbi.nlm.nih.gov/pubmed/34768503 http://dx.doi.org/10.3390/jcm10214984 |
work_keys_str_mv | AT bassipierfrancesco improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT digianfrancescoluca improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT salmasoluigi improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT ragonesemauro improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT palermogiuseppe improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT saccoemilio improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT giancristofarorosaarboretti improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT ceccatoriccardo improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy AT racioppimarco improvednoninvasivediagnosisofbladdercancerwithanelectronicnosealargepilotstudy |